28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Revisiting Statins in Multiple Sclerosis
Andrew N. Wilner, MD;
Jeremy S. Chataway, PhD

Sequencing the Parade of MS Therapies
Andrew N. Wilner, MD;
Paul W. O'Connor, MD, MSc

A New Drug, a New Test, and a Final Word on CCSVI
Andrew N. Wilner, MD;
Mark S. Freedman, MD

Environmental Risk Factors for MS: Not Just Chance Phenomena
Andrew N. Wilner, MD;
Edward J. Fox, MD, PhD

Is There a Future for Injectables in MS?
Andrew N. Wilner, MD;
Daniel Kantor, MD

A Promising New Approach in MS Therapy
Andrew N. Wilner, MD;
Mark. S. Freedman, MD

Combo Therapy in MS: Ready or Not?
Andrew N. Wilner, MD;
Fred D. Lublin, MD

Oral MS Agents: And Then There Were Two
Andrew N. Wilner, MD;
Lily Jung Henson, MD, MMM

5th Joint Triennial Congress of ECTRIMS/ACTRIMS

26th Congress of ECTRIMS

25th Congress of ECTRIMS